Utah Medical Products (UTMD) Income from Continuing Operations (2010 - 2026)

Utah Medical Products' Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 2604000.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations fell 14.37% year-over-year to 2604000.0; the TTM figure through Mar 2026 stood at 8537000.0 (down 32.35% YoY), while the FY2025 annual figure was 8974000.0, up 3835.96% from the prior year.
• Income from Continuing Operations was 2604000.0 for Q1 2026 at Utah Medical Products, up from 254000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 4280000.0 in Q3 2022 to a low of 8366000.0 in Q4 2022.
• Historically, Income from Continuing Operations has averaged 2103411.76 across 5 years, with a median of 3453000.0 in 2024.
• The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations slumped 289.19% in 2022, then jumped 148.76% in 2024.
• A 5-year view of Income from Continuing Operations shows it stood at 8366000.0 in 2022, then soared by 37.2% to 5254000.0 in 2023, then surged by 148.76% to 2562000.0 in 2024, then plunged by 90.09% to 254000.0 in 2025, then surged by 925.2% to 2604000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 2604000.0 (Q1 2026), 254000.0 (Q4 2025), and 2631000.0 (Q3 2025), per Business Quant data.